PD-L1 targeting in triple negative breast cancer: in silico and in vitro validation of wasp venom peptide MP-1.

Triple-negative breast cancer is an aggressive cancer with high metastatic potential and limited treatment options. The current study investigated the anticancer activity of the Polybia-derived MP-1 peptide, formulated in poly (lactic-co-glycolic aci…

Preview only. Read the full abstract at the source